NasdaqGS:MRNABiotechs
Has The Market Rerated Moderna (MRNA) Too Quickly After Its Recent Share Price Surge?
Wondering whether Moderna's current share price still reflects its true value, or if the market has moved on too quickly.
The stock closed at US$46.71, with a 51.4% return year to date and a 91.2% return over the last year, set against weaker 3 year and 5 year returns of 65.1% and 70.6% declines.
These swings in performance come as Moderna continues to be closely watched by investors, with sentiment moving between enthusiasm and caution. That backdrop helps explain why the stock has had...